<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 2.1: Cardiovascular Risks in the Post-Estrogen Era</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/NAVY theme for Vascular Health */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0e7ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f8fafc;
            color: #1e3a8a;
            padding: 16px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #f1f5f9;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
            margin-top: 10px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f9f9f9;
            border-radius: 12px;
            font-size: 14px;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 2: Vascular & Bone Integrity (The 'V' in VITAL)</p>
            <h1 class="lesson-title">Lesson 2.1: Cardiovascular Risks in the Post-Estrogen Era</h1>
            <div class="lesson-meta">
                <span class="meta-item">30 min read</span>
                <span class="meta-item">Lesson 1 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Estrogen Shield</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Arterial Elasticity & NO</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Post-Menopausal Lipid Shift</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Endothelial Dysfunction</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Screening & Assessment</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Coaching for Heart Health</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the physiological mechanisms by which estrogen protects the female vascular system.</li>
                <li>Analyze the specific changes in lipid profiles and blood pressure that occur during the menopause transition.</li>
                <li>Identify the role of Nitric Oxide (NO) in maintaining endothelial health and arterial compliance.</li>
                <li>Distinguish between chronological aging and hormonal-driven cardiovascular risk factors.</li>
                <li>Implement evidence-based lifestyle strategies to mitigate vascular risk in post-menopausal clients.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Silent Transition</h3>
            <p>While hot flashes and night sweats garner the most attention, the most profound shift during menopause happens within the <span class="highlight">vascular endothelium</span>. For nearly four decades, estrogen acts as a "biological shield," keeping arteries supple and cholesterol levels balanced. When this shield is removed, a woman's cardiovascular risk profile rapidly accelerates, often catching up to or exceeding that of men. As a Menopause Support Coach, your role in identifying and addressing these "silent" risks is literally life-saving.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Endothelium</p>
                    <p class="definition">The thin layer of cells lining the blood vessels that regulates vascular tone and blood flow.</p>
                </div>
                <div class="term-item">
                    <p class="term">Nitric Oxide (NO)</p>
                    <p class="definition">A signaling molecule produced by the endothelium that triggers vasodilation (widening of the arteries).</p>
                </div>
                <div class="term-item">
                    <p class="term">Atherosclerosis</p>
                    <p class="definition">The buildup of fats, cholesterol, and other substances in and on the artery walls (plaque).</p>
                </div>
                <div class="term-item">
                    <p class="term">Lipid Triad</p>
                    <p class="definition">The common menopausal pattern of high LDL, low HDL, and elevated triglycerides.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The Estrogen Shield: Why Risks Skyrocket</h2>
        <p>Cardiovascular disease (CVD) is the <span class="highlight">leading cause of death</span> for women globally. However, many women remain unaware that their risk changes fundamentally at the onset of menopause. A 2023 meta-analysis of over 1.2 million women found that early menopause (before age 45) was associated with a 36% higher risk of coronary heart disease.</p>
        
        <p>Estrogen influences the heart and blood vessels through both genomic and non-genomic pathways. It binds to estrogen receptors (ERÎ± and ERÎ²) located directly on the vascular smooth muscle cells and the endothelium. This interaction promotes the production of protective proteins and inhibits the inflammatory processes that lead to plaque formation.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">1 in 3</div>
                    <div class="stat-label">Women Die of CVD</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10-15%</div>
                    <div class="stat-label">Increase in LDL Post-Meno</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2x</div>
                    <div class="stat-label">Hypertension Risk Increase</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">60%</div>
                    <div class="stat-label">Loss of NO Production</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Arterial Elasticity and the Role of Nitric Oxide</h2>
        <p>One of estrogen's most critical functions is stimulating the enzyme <span class="highlight">eNOS (endothelial nitric oxide synthase)</span>. This enzyme produces Nitric Oxide, the primary molecule responsible for keeping arteries flexible. When estrogen levels drop, NO production plummets by as much as 60%.</p>
        
        <p>The result is "arterial stiffness." Instead of expanding to accommodate blood flow, the arteries remain rigid. This increases systolic blood pressure and places immense strain on the left ventricle of the heart. This transition is often measured by <span class="highlight">Pulse Wave Velocity (PWV)</span>, which typically increases significantly during the late perimenopause phase.</p>

        <h2 id="section3">The Post-Menopausal Lipid Shift</h2>
        <p>The removal of estrogen fundamentally alters how the liver processes lipids. Estrogen normally increases the expression of LDL receptors in the liver, which helps "clear" bad cholesterol from the blood. Without this mechanism, LDL levels often rise even if the client's diet remains unchanged.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Marker</th>
                        <th>Pre-Menopause Profile</th>
                        <th>Post-Menopause Shift</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>LDL-C</strong></td>
                        <td>Lower, larger particles</td>
                        <td>Increased (10-20%)</td>
                        <td>Increased plaque potential</td>
                    </tr>
                    <tr>
                        <td><strong>HDL-C</strong></td>
                        <td>Higher, more "efflux" capacity</td>
                        <td>Decreased or less functional</td>
                        <td>Reduced "scavenging" of fat</td>
                    </tr>
                    <tr>
                        <td><strong>Triglycerides</strong></td>
                        <td>Regulated by estrogen</td>
                        <td>Increased (15-25%)</td>
                        <td>Marker of metabolic dysfunction</td>
                    </tr>
                    <tr>
                        <td><strong>Lp(a)</strong></td>
                        <td>Stable</td>
                        <td>Can increase by up to 30%</td>
                        <td>High genetic cardiovascular risk</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">Endothelial Dysfunction: The Invisible Driver</h2>
        <p>Endothelial dysfunction is the "canary in the coal mine" for cardiovascular disease. It precedes the visible buildup of plaque by years. In the post-estrogen era, the endothelium becomes "pro-thrombotic" (likely to clot) and "pro-inflammatory."</p>
        
        <p>This is further complicated by the shift toward <span class="highlight">visceral adiposity</span> (belly fat). Visceral fat is not just stored energy; it is an active endocrine organ that secretes inflammatory cytokines like IL-6 and TNF-alpha. these cytokines travel directly to the vascular system, further damaging the endothelial lining and accelerating atherosclerosis.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Lipid Surprise</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Addressing Sudden Hyperlipidemia in Post-Menopause</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah J., Age 54</h4>
                        <p>2 Years Post-Menopause | Former Runner | "Healthy Eater"</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Sarah was shocked when her annual physical showed her LDL had jumped from 115 mg/dL to 168 mg/dL in 18 months. Her blood pressure, previously 110/70, was now 138/88. She felt "puffy" and noticed more fat around her midsection despite no changes in her caloric intake.</p>
                <p><strong>Intervention (VITAL Method):</strong>
                    <ul>
                        <li><strong>Vascular Focus:</strong> Introduced 3g of daily EPA/DHA to reduce inflammation and support endothelial function.</li>
                        <li><strong>Nutrition:</strong> Increased soluble fiber to 35g/day (via legumes and flax) to assist in fecal bile acid excretion.</li>
                        <li><strong>Movement:</strong> Switched from long-distance running to "Sprint Interval Training" (SIT) to stimulate NO production.</li>
                    </ul>
                </p>
                <p><strong>Outcome:</strong> After 4 months, Sarah's LDL dropped to 132 mg/dL. Her blood pressure normalized to 122/78. Most importantly, she understood that her body's "machinery" had changed, requiring a more targeted vascular strategy.</p>
            </div>
        </div>

        <h2 id="section5">Screening and Assessment for Coaches</h2>
        <p>As a coach, you do not diagnose, but you must know which markers to request from a client's physician to assess vascular integrity. A standard lipid panel is often insufficient to see the whole picture.</p>
        
        <p>Consider the <span class="highlight">ApoB (Apolipoprotein B)</span> test. While LDL-C measures the *weight* of the cholesterol, ApoB measures the *number* of atherogenic particles. In post-menopausal women, the number of particles often increases more than the total weight, making ApoB a more accurate predictor of risk.</p>

        <h2 id="section6">The V.I.T.A.L. Approach to Vascular Longevity</h2>
        <p>Managing the "V" in VITAL requires a multi-pronged approach that mimics some of the benefits lost with estrogen. We focus on three primary pillars:</p>
        
        <div style="background: #f1f5f9; padding: 25px; border-radius: 12px; margin-bottom: 30px;">
            <p><strong>1. Dietary Nitrates:</strong> Foods like arugula, beets, and spinach provide inorganic nitrates that the body can convert into Nitric Oxide, bypassing the damaged eNOS pathway.</p>
            <p><strong>2. Resistance Training:</strong> Lifting heavy weights creates "shear stress" on the artery walls, which is a powerful stimulus for vascular remodeling and elasticity.</p>
            <p><strong>3. Omega-3 Optimization:</strong> High-dose Omega-3s (specifically EPA) help stabilize the endothelial membrane and reduce the "stickiness" of the blood.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge on menopausal vascular health.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why does blood pressure often rise during the menopause transition even if a woman is not overweight?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The decline in estrogen leads to a significant reduction in Nitric Oxide (NO) production. This causes the arteries to become stiffer (loss of elasticity), which increases the pressure required to pump blood through the system.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">How does estrogen loss affect the liver's handling of LDL cholesterol?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Estrogen normally upregulates LDL receptors in the liver. When estrogen levels fall, the liver becomes less efficient at clearing LDL particles from the bloodstream, leading to higher circulating levels of "bad" cholesterol.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Estrogen is a potent vasodilator and anti-inflammatory agent that protects the female heart for decades.</li>
                <li>The menopause transition is characterized by a "Lipid Shift" (High LDL, low HDL, high Triglycerides).</li>
                <li>Arterial stiffness, measured by Pulse Wave Velocity, increases as Nitric Oxide production declines.</li>
                <li>Lifestyle interventions must focus on "NO-boosting" foods and resistance training to maintain vascular compliance.</li>
                <li>Advanced markers like ApoB and Lp(a) provide a more accurate risk assessment than standard lipid panels alone.</li>
            </ul>
        </div>

        <div class="references-box">
            <p style="font-weight: 700; margin-bottom: 15px; color: #1e3a8a;">References & Further Reading</p>
            <p>El Khoudary et al. (2020). "Menopause Transition and Cardiovascular Disease Risk: Implications for Health Care Professionals." <em>Circulation</em>.</p>
            <p>Muka et al. (2016). "Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis." <em>JAMA Cardiology</em>.</p>
            <p>Samargandy et al. (2021). "Arterial Stiffness Accelerates Within 1 Year of the Final Menstrual Period: The SWAN Heart Study." <em>Arteriosclerosis, Thrombosis, and Vascular Biology</em>.</p>
            <p>Nappi et al. (2022). "The Endothelium in Menopause: A Review of the Effects of Estrogen on the Vascular System." <em>Maturitas</em>.</p>
            <p>Grundy et al. (2019). "AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol." <em>Journal of the American College of Cardiology</em>.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Certified Menopause Support Coach | Module 2: Vascular & Bone Integrity</p>
        </footer>
    </div>
</body>

</html>